Did the FDA approve the first drug to treat Alexander disease?
Yes. In September 2026 the U.S. Food and Drug Administration approved Zanvastro, the first and only disease-modifying treatment for Alexander disease — a rare, progressive neurological disorder that can impair motor, cognitive, and autonomic function. Until this approval, care was limited to managing symptoms. The drug grew out of more than 30 years of research … Read more